Clinical outcomes and late toxicities after high dose rate brachytherapy combined with hypofractionated external beam radiation therapy for intermediate-high risk prostate cancer

被引:0
|
作者
Akimoto, T. [1 ]
Katoh, H. [1 ]
Shirai, K. [1 ]
Harada, K. [1 ]
Ito, K. [1 ]
Yamamoto, T. [1 ]
Nakano, T. [1 ]
机构
[1] Gunma Univ, Sch Med, Gunma 3718511, Japan
关键词
D O I
10.1016/j.ijrobp.2006.07.726
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2318
引用
收藏
页码:S387 / S388
页数:2
相关论文
共 50 条
  • [31] Genitourinary (GU) Toxicity in Patients with Intermediate and High-Risk Prostate Cancer Managed with Hypofractionated External Radiation and High Dose Rate (HDR) Brachytherapy Boost
    Goel, A.
    Liu, C. M.
    Kaur, P.
    Wong, M. L.
    Scala, L. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E113 - E113
  • [32] High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term androgen deprivation therapy for very high-risk prostate cancer
    Kasahara, Takashi
    Ishizaki, Fumio
    Kazama, Akira
    Yuki, Eri
    Yamana, Kazutoshi
    Maruyama, Ryo
    Oshikane, Tomoya
    Kaidu, Motoki
    Aoyama, Hidefumi
    Bilim, Vladimir
    Nishiyama, Tsutomu
    Tomita, Yoshihiko
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (09) : 800 - 806
  • [33] Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancer
    Gorovets, Daniel
    Hopkins, Margaret
    Kollmeier, Marisa
    Moore, Assaf
    Goel, Arun
    Shasha, Daniel
    Brennan, Victoria
    McBride, Sean
    Cohen, Gilad
    Damato, Antonio L.
    Zelefsky, Michael J.
    BRACHYTHERAPY, 2021, 20 (06) : 1099 - 1106
  • [34] A combined single high-dose rate brachytherapy boost with hypofractionated external beam radiotherapy results in a high rate of biochemical disease free survival in localised intermediate and high risk prostate cancer patients
    Joseph, Nuradh
    Taylor, Cathy
    O'Hara, Catherine
    Choudhury, Ananya
    Elliott, Tony
    Logue, John
    Wylie, James
    RADIOTHERAPY AND ONCOLOGY, 2016, 121 (02) : 299 - 303
  • [35] TOXICITY ASSOCIATED WITH HIPOFRACTIONATED EXTERNAL BEAM RADIOTHERAPY AND INTERSTITIAL HIGH DOSE RATE BRACHYTHERAPY AND FOR INTERMEDIATE AND HIGH RISK PROSTATE CANCER
    Pellizzon, A.
    RADIOTHERAPY AND ONCOLOGY, 2009, 91 : S56 - S56
  • [36] Cost-effectiveness of prostate boost with high-dose-rate brachytherapy versus intensity-modulated radiation therapy in the treatment of intermediate-high risk prostate cancer
    Vu, Charles C.
    Blas, Kevin G.
    Lanni, Thomas B.
    Gustafson, Gary S.
    Krauss, Daniel J.
    BRACHYTHERAPY, 2018, 17 (06) : 852 - 857
  • [37] PSA RESPONSE TO NEOADJUVANT ANDROGEN SUPPRESSION THERAPY PRIOR TO HIGH DOSE RATE BRACHYTHERAPY COMBINED WITH HYPOFRACTIONATED EXTERNAL BEAM RADIATION THERAPY PREDICTS BIOCHEMICAL PROGRESSION FREE SURVIVAL IN LOCALIZED HIGH RISK PROSTATE CANCER
    Aoki, M.
    Miki, K.
    Masahito, K.
    Yamamoto, J.
    Takaki, S.
    Kobayashi, M.
    Kanehira, C.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S388 - S388
  • [38] Four-year outcomes of hypofractionated high-dose-rate prostate brachytherapy and external beam radiotherapy
    Chen, William C.
    Tokita, Kenneth M.
    Ravera, John
    Fu, Pingfu
    Jiang, Ying
    Kaminsky, Deborah A.
    Ponsky, Lee
    Ellis, Rodney J.
    BRACHYTHERAPY, 2013, 12 (05) : 422 - 427
  • [39] Long-term chronic toxicity profile of a dose escalating hypofractionated pelvic external beam radiation therapy (EBRT) with a high dose rate Brachytherapy (HDR-BT) boost for intermediate and high risk prostate cancer
    Marvin, K.
    Wallace, M.
    Ghilezan, M.
    Gustafson, G.
    Kestin, L.
    Sebastian, E.
    Martinez, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S95 - S96
  • [40] Improving the results of intermediate risk prostate cancer treated with high dose rate (HDR) brachytherpy and hypofractionated external beam radiation therpy author
    Cury, F.
    Duclos, M.
    Aprikian, A.
    Shenouda, G.
    Faria, S.
    David, M.
    Patrocinio, H.
    Evans, M.
    Souhami, L.
    RADIOTHERAPY AND ONCOLOGY, 2007, 84 : S15 - S15